Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Sexually dimorphic, developmental, and chronobiological behavioral profiles of a mouse mania model.

Saul MC, Stevenson SA, Gammie SC.

PLoS One. 2013 Aug 13;8(8):e72125. doi: 10.1371/journal.pone.0072125. eCollection 2013.

2.

Behavioral and pharmacological assessment of a potential new mouse model for mania.

Scotti MA, Lee G, Stevenson SA, Ostromecki AM, Wied TJ, Kula DJ, Gessay GM, Gammie SC.

Physiol Behav. 2011 Jun 1;103(3-4):376-83. doi: 10.1016/j.physbeh.2011.03.005. Epub 2011 Mar 22.

3.

A new mouse model for mania shares genetic correlates with human bipolar disorder.

Saul MC, Gessay GM, Gammie SC.

PLoS One. 2012;7(6):e38128. doi: 10.1371/journal.pone.0038128. Epub 2012 Jun 4.

4.

Further evidence for ClockΔ19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating.

van Enkhuizen J, Minassian A, Young JW.

Behav Brain Res. 2013 Jul 15;249:44-54. doi: 10.1016/j.bbr.2013.04.023. Epub 2013 Apr 23.

5.

GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.

Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA.

Psychopharmacology (Berl). 2010 Feb;208(3):443-54. doi: 10.1007/s00213-009-1744-8. Epub 2009 Dec 18.

6.

A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men.

Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry BL, Zhuang X, Masten VL, Sharp RF, Geyer MA.

Arch Gen Psychiatry. 2009 Oct;66(10):1072-80. doi: 10.1001/archgenpsychiatry.2009.58.

7.

The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.

Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA.

Pharmacol Biochem Behav. 2010 Jul;96(1):7-15. doi: 10.1016/j.pbb.2010.03.014. Epub 2010 Apr 2.

8.

Attenuation of mania-like behavior in Na(+),K(+)-ATPase α3 mutant mice by prospective therapies for bipolar disorder: melatonin and exercise.

Kirshenbaum GS, Burgess CR, Déry N, Fahnestock M, Peever JH, Roder JC.

Neuroscience. 2014 Feb 28;260:195-204. doi: 10.1016/j.neuroscience.2013.12.011. Epub 2013 Dec 14.

PMID:
24342563
9.

Sex differences in mania phenotype and ethanol consumption in the lateral hypothalamic kindled rat model.

Abulseoud OA, Gawad NA, Mohamed K, Vadnie C, Camsari UM, Karpyak V, Frye MA, Choi DS.

Transl Psychiatry. 2015 Mar 24;5:e534. doi: 10.1038/tp.2015.30.

10.

Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the ClockΔ19 mouse model of mania.

Coque L, Mukherjee S, Cao JL, Spencer S, Marvin M, Falcon E, Sidor MM, Birnbaum SG, Graham A, Neve RL, Gordon E, Ozburn AR, Goldberg MS, Han MH, Cooper DC, McClung CA.

Neuropsychopharmacology. 2011 Jun;36(7):1478-88. doi: 10.1038/npp.2011.33. Epub 2011 Mar 23.

11.

The circadian system of patients with bipolar disorder differs in episodes of mania and depression.

Nováková M, Praško J, Látalová K, Sládek M, Sumová A.

Bipolar Disord. 2015 May;17(3):303-14. doi: 10.1111/bdi.12270. Epub 2014 Oct 31.

PMID:
25359533
12.

The effects of n-acetylcysteine and/or deferoxamine on manic-like behavior and brain oxidative damage in mice submitted to the paradoxal sleep deprivation model of mania.

Arent CO, Valvassori SS, Steckert AV, Resende WR, Dal-Pont GC, Lopes-Borges J, Amboni RT, Bianchini G, Quevedo J.

J Psychiatr Res. 2015 Jun;65:71-9. doi: 10.1016/j.jpsychires.2015.04.011. Epub 2015 Apr 18.

PMID:
25937502
13.

Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice.

Einat H.

Pharmacol Rep. 2014 Aug;66(4):722-5. doi: 10.1016/j.pharep.2014.03.013. Epub 2014 Apr 16.

PMID:
24948079
14.

Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.

Young JW, van Enkhuizen J, Winstanley CA, Geyer MA.

J Psychopharmacol. 2011 Jul;25(7):934-43. doi: 10.1177/0269881111400646. Epub 2011 Mar 18.

15.

Behavioural sensitization to repeated sleep deprivation in a mice model of mania.

Benedetti F, Fresi F, Maccioni P, Smeraldi E.

Behav Brain Res. 2008 Mar 5;187(2):221-7. Epub 2007 Sep 14.

PMID:
17950929
16.

Different behaviors and different strains: potential new ways to model bipolar disorder.

Einat H.

Neurosci Biobehav Rev. 2007;31(6):850-7. Epub 2007 Jan 17. Review.

PMID:
17307253
17.

Modelling facets of mania--new directions related to the notion of endophenotypes.

Einat H.

J Psychopharmacol. 2006 Sep;20(5):714-22. Epub 2006 Jan 9. Review.

PMID:
16401660
18.

Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.

Papolos D, Mattis S, Golshan S, Molay F.

J Affect Disord. 2009 Nov;118(1-3):28-38. doi: 10.1016/j.jad.2009.06.016. Epub 2009 Jul 23.

PMID:
19631388
19.

Partial effects of the AMPAkine CX717 in a strain specific battery of tests for manic-like behavior in black Swiss mice.

Kara NZ, Flaisher-Grinberg S, Einat H.

Pharmacol Rep. 2015 Oct;67(5):928-33. doi: 10.1016/j.pharep.2015.02.008. Epub 2015 Mar 4.

PMID:
26398387
20.

Predictive animal models of mania: hits, misses and future directions.

Young JW, Henry BL, Geyer MA.

Br J Pharmacol. 2011 Oct;164(4):1263-84. doi: 10.1111/j.1476-5381.2011.01318.x. Review.

Supplemental Content

Support Center